Brief: Lantheus Announces Agreement To Sell RELISTOR Royalties To Healthcare Royalty
03/08/2023 15:23
Aug 3 (Reuters) - Lantheus Holdings Inc LNTH.O :
* LANTHEUS ANNOUNCES AGREEMENT TO SELL RELISTOR® ROYALTIES
TO
HEALTHCARE ROYALTY
* LANTHEUS HOLDINGS INC - UNDER TERMS OF PURCHASE AGREEMENT,
LANTHEUS RECEIVED AN INITIAL PAYMENT OF APPROXIMATELY $98
MILLION
* LANTHEUS - HAS RIGHT TO ALSO RECEIVE ADDITIONAL PAYMENT OF
$5
MILLION FROM HCRX IF WORLDWIDE NET SALES OF RELISTOR IN 2025
EXCEED SPECIFIED THRESHOLD
Source text for Eikon: ID:nGNXSKhFr
Further company coverage: LNTH.O
((Reuters.Brief@thomsonreuters.com;))
Recent news on Lantheus Holdings
See all newsStreet View: Lantheus' tumor kit setback seen as temporary, with growth catalysts still ahead
Brief: Lantheus Receives Complete Response Letter From FDA For Lnth-2501 (Ga 68 Edotreotide)
US FDA declines Lantheus’ tumor imaging kit over third-party manufacturing issues (updated)
US FDA declines to approve Lantheus’ tumor imaging kit
$7 billion could be a 'light' price tag for Lantheus, Truist analysts say